Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about SciSparc
Recent news which mentions SciSparc
SciSparc, Deere & Company, Baidu, Marathon Digital, Tesla: Why These 5 Stocks Are On Investors' Radars Today
November 22, 2023
Tickers
BIDU
DE
EVS
MARA
Tags
automotive
Equities
TSLA
From
Benzinga
SciSparc Signs LOI to Sell 50% Interest in Subsidiary
December 15, 2022
Tickers
JFBR
SPRC
Tags
Market News
SciSparc
Penny Stocks
From
Benzinga
Can This Company's Positive Results For Psychedelic Combination Treatment Provide Hope For Alcohol And Cocaine Addiction Problems?
November 15, 2022
Tickers
AMPH
Tags
General
Biotech
Partner Content
From
Benzinga
SciSparc Nutraceuticals Signs Agreement With Logistics Facilities, Expected To Optimize Handling and Shipment Processes and Reduce Direct Sales Costs
November 02, 2022
Tickers
SPRC
Tags
News
Market News
SciSparc
From
Benzinga
SciSparc Enters Agreement to Acquire Wellution™, Top Seller of American Food Supplements and Cosmetics Brand on Amazon, for $20 million
September 14, 2022
Tickers
SPRC
Tags
Press Releases
SciSparc
Market News
From
Benzinga
Additional Positive Results Revealed In Cocaine Addiction Treatment Through SciSparc-Clearmind Collaboration
August 25, 2022
Tickers
CMNDF
SPRC
Tags
SciSparc
Market News
SPRC
From
Benzinga
SciSparc Ltd. Announces Additional Positive Results for the Cocaine Addiction Treatment of its Psychedelic-based Pharma Collaboration with Clearmind Medicine Inc.
August 25, 2022
Tickers
CMNDF
SPRC
Tags
Market News
SciSparc
Penny Stocks
From
Benzinga
Psychedelic-Based Cocaine Addiction Treatment Study Showing Positive Results. This Is What We Know
August 24, 2022
Tickers
CMNDF
SPRC
Tags
Clearmind Medicine
SciSparc
Markets
From
Benzinga
SciSparc Issued Israeli Patent For Its Core Technology For Treating Central Nervous Systems Disorders
August 12, 2022
Tickers
SPRC
Tags
Market News
SciSparc
SPRC
From
Benzinga
These Biotechs Are Reportedly Reinvigorating Alzheimer's Disease Research With Novel Drugs That Push Beyond Traditional Approaches
July 20, 2022
Tickers
BIIB
LLY
PFE
SAVA
Tags
SciSparc
General
Partner Content
From
Benzinga
SciSparc Announces Buyback Equal To 12% Of Float
July 07, 2022
Tickers
SPRC
Tags
Penny Stocks
Benzinga
SPRC
From
Benzinga
SciSparc Completes Development Of Its Proprietary Drug Candidate SCI-110 To Treat Tourette Syndrome
June 30, 2022
Tickers
SPRC
Tags
Partner Content
News
Biotech
From
Benzinga
SciSparc Successfully Completed The Development Of Its Proprietary Drug Candidate SCI-110 For Its Upcoming Phase IIb Study In Tourette Syndrome
June 29, 2022
Tickers
SPRC
Tags
Partner Content
Press Releases
SciSparc
From
Benzinga
SciSparc And Polyrizon Report Joining Forces To Develop A Non-Opioid Pain Relief Nasal Spray
June 28, 2022
Tickers
ABC
CAH
JNJ
MCK
Tags
Partner Content
General
JNJ
From
Benzinga
SciSparc Receives Ethics Committee Approval To Conduct Clinical Trial In ASD With Proprietary SCI-210 Treatment
June 24, 2022
Tickers
SPRC
Tags
Benzinga
SPRC
Penny Stocks
From
Benzinga
SciSparc Announces Ethics Committee Approval To Conduct Its Clinical Trial In Autism Spectrum Disorder
June 23, 2022
Tickers
SPRC
Tags
Market News
SciSparc
Benzinga
From
Benzinga
SciSparc Reinforces Its New JV For Targeting Discovery With A Global Expert In The Field Of Mitochondrial Transport Proteins
June 15, 2022
Tickers
SPRC
Tags
Market News
SciSparc
Penny Stocks
From
Benzinga
Initial Positive Results For Cocaine Addiction Treatment Announced
June 08, 2022
Tickers
SPRC
Tags
General
News
Biotech
From
Benzinga
SciSparc Ltd. Announces Initial Positive Results For The Cocaine Addiction Treatment Of Clearmind Medicine Inc.
June 07, 2022
Tickers
CMNDF
SPRC
Tags
Press Releases
Biotech
CMNDF
From
Benzinga
SciSparc Ltd. and Clearmind Medicine Inc. Collaboration Yields Another Patent Application for their Proprietary Psychedelic Combination to Treat Cocaine Addiction
June 02, 2022
Tickers
CMNDF
SPRC
Tags
Market News
SciSparc
SPRC
From
Benzinga
SciSparc To Collaborate With Polyrizon For Brain Targeting Using Intranasal Hydrogel Systems
May 31, 2022
Tickers
SPRC
Tags
SciSparc
Market News
Benzinga
From
Benzinga
SciSparc Gets Ethics Committee Approval In Germany And Israel Sites To Conduct A Phase IIb Trial In Tourette Syndrome
May 27, 2022
Tickers
SPRC
Tags
Market News
SciSparc
Benzinga
From
Benzinga
SciSparc Announces Ethics Committee Approval to Conduct a Phase IIb Trial In Tourette Syndrome
May 26, 2022
Tickers
SPRC
Tags
Market News
SciSparc
SPRC
From
Benzinga
Positive Phase 2 Results Of SciSparc's Cannabinoid-Based Drug Candidate May Offer Some New Hope To Tourette Syndrome Patients
May 25, 2022
Tickers
JNJ
RDY
SPRC
Tags
Penny Stocks
RDY
Benzinga
From
Benzinga
SciSparc And Clearmind Medicine Inc. Collaboration Yields Positive Results For Its Psychedelic Combination Treatment
May 24, 2022
Tickers
SPRC
Tags
Market News
SciSparc
Markets
From
Benzinga
SciSparc Reports Developing Cannabinoids Based Acute Pain Relief Alternative To Help Counter Opioid Crisis
May 18, 2022
Tickers
ABC
JNJ
SPRC
Tags
SPRC
Benzinga
Penny Stocks
From
Benzinga
SciSparc Reports Developing Cannabinoids Based Acute Pain Relief Alternative To Help Counter Opioid Crisis
May 18, 2022
Tickers
ABC
JNJ
SPRC
Tags
ABC
Partner Content
Psychedelics
From
Benzinga
SciSparc Issued Israeli Patent For Its Core Technology For Treating Central Nervous Systems Disorders
May 17, 2022
Tickers
SPRC
Tags
General
Partner Content
Biotech
From
Benzinga
Has Clearmind Developed A Psychedelics-Based Drug That Can Treat Alcoholism? The FDA Is Interested
May 13, 2022
Tickers
CMNDF
SPRC
Tags
CDER
SPRC
Benzinga
From
Benzinga
The Hidden Potential Of The Endocannabinoid System? SciSparc Says Its Portfolio Of Cannabinoids-Derived Drug Candidates Tap The Body's Natural System
May 12, 2022
Tickers
SPRC
Tags
Penny Stocks
Benzinga
SPRC
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.